Tumors expressing HER2 showed a higher prevalence of MMTV-like env in tumor tissue, with the highest prevalence being observed in tumors from the HER2-enriched subtype (38.5%), followed by those from the Luminal-B subtype (25.0%). Here, ERBB2 is linked to neoplasm.